NO993067L - Farmasoeytiske sammensetninger for frysetoerking - Google Patents

Farmasoeytiske sammensetninger for frysetoerking

Info

Publication number
NO993067L
NO993067L NO993067A NO993067A NO993067L NO 993067 L NO993067 L NO 993067L NO 993067 A NO993067 A NO 993067A NO 993067 A NO993067 A NO 993067A NO 993067 L NO993067 L NO 993067L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
freeze drying
freeze
drying
pharmaceutical
Prior art date
Application number
NO993067A
Other languages
English (en)
Other versions
NO327142B1 (no
NO993067D0 (no
Inventor
Chris Bland
Gerald Steele
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO993067D0 publication Critical patent/NO993067D0/no
Publication of NO993067L publication Critical patent/NO993067L/no
Publication of NO327142B1 publication Critical patent/NO327142B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19993067A 1996-12-20 1999-06-21 Farmasoytisk preparat som omfatter en nukleotidanalog, mannitol og et modifiserende additiv, anvendelse av nevnte preparat samt fremgangsmate for dets fremstilling NO327142B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604795A SE9604795D0 (sv) 1996-12-20 1996-12-20 New pharmaceutical formulation
PCT/SE1997/002068 WO1998028009A1 (en) 1996-12-20 1997-12-11 Pharmaceutical compositions for freeze drying

Publications (3)

Publication Number Publication Date
NO993067D0 NO993067D0 (no) 1999-06-21
NO993067L true NO993067L (no) 1999-08-09
NO327142B1 NO327142B1 (no) 2009-05-04

Family

ID=20405148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993067A NO327142B1 (no) 1996-12-20 1999-06-21 Farmasoytisk preparat som omfatter en nukleotidanalog, mannitol og et modifiserende additiv, anvendelse av nevnte preparat samt fremgangsmate for dets fremstilling

Country Status (36)

Country Link
US (1) US6114313A (no)
EP (1) EP1007094B1 (no)
JP (1) JP4488538B2 (no)
KR (1) KR100552880B1 (no)
CN (1) CN1121875C (no)
AR (1) AR010377A1 (no)
AT (1) ATE221787T1 (no)
AU (1) AU758857B2 (no)
BR (1) BR9713974B1 (no)
CA (1) CA2275153C (no)
CZ (1) CZ300635B6 (no)
DE (1) DE69714616T2 (no)
DK (1) DK1007094T3 (no)
EE (1) EE03857B1 (no)
ES (1) ES2182133T3 (no)
FR (1) FR15C0060I2 (no)
HK (1) HK1026366A1 (no)
HU (1) HU226616B1 (no)
ID (1) ID21635A (no)
IL (1) IL130449A0 (no)
IS (1) IS1897B (no)
MY (1) MY121982A (no)
NO (1) NO327142B1 (no)
NZ (1) NZ336027A (no)
PL (1) PL190493B1 (no)
PT (1) PT1007094E (no)
RU (1) RU2205012C2 (no)
SA (1) SA97180719B1 (no)
SE (1) SE9604795D0 (no)
SI (1) SI1007094T1 (no)
SK (1) SK283137B6 (no)
TR (1) TR199901412T2 (no)
TW (1) TW522015B (no)
UA (1) UA66779C2 (no)
WO (1) WO1998028009A1 (no)
ZA (1) ZA9711055B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702680D0 (sv) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation
US9925265B2 (en) 2009-11-11 2018-03-27 Chiesi Farmaceutici S.P.A. Methods of treating or preventing stent thrombosis
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
US8759316B2 (en) 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20130303477A1 (en) 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US20120141468A1 (en) * 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
CN103582480B (zh) 2011-02-09 2016-03-16 医药公司 治疗肺高压的方法
EA034550B1 (ru) 2013-03-09 2020-02-19 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способы лечения, снижения частоты и/или профилактики ишемических событий
CN103772461A (zh) * 2014-01-06 2014-05-07 南京正科制药有限公司 一种坎格雷洛晶型ⅰ
US9295687B1 (en) 2015-01-14 2016-03-29 The Medicines Company Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
MA49452A (fr) 2017-06-23 2021-05-05 Chiesi Farm Spa Procédé de prévention de thrombose de shunt de l'artère systémique-pulmonaire

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637967B2 (no) * 1973-05-17 1981-09-03
JPH01228915A (ja) * 1988-03-09 1989-09-12 Dai Ichi Seiyaku Co Ltd Ａｔｐ凍結乾燥製剤
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
CZ281415B6 (cs) * 1989-11-09 1996-09-11 Masarykova Nemocnice S Poliklinikou Iii. Typu Způsob přípravy přenosového faktoru z buffy coatu savčí krve
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US5563122A (en) * 1991-12-09 1996-10-08 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition

Also Published As

Publication number Publication date
SE9604795D0 (sv) 1996-12-20
KR100552880B1 (ko) 2006-02-20
ZA9711055B (en) 1998-07-08
US6114313A (en) 2000-09-05
AU5351598A (en) 1998-07-17
AR010377A1 (es) 2000-06-07
TW522015B (en) 2003-03-01
EE9900260A (et) 2000-02-15
TR199901412T2 (xx) 1999-08-23
SK76499A3 (en) 1999-11-08
EP1007094B1 (en) 2002-08-07
EE03857B1 (et) 2002-10-15
IS1897B (is) 2003-10-20
CA2275153C (en) 2008-03-25
CZ220199A3 (cs) 1999-11-17
NZ336027A (en) 2001-03-30
IL130449A0 (en) 2000-06-01
HK1026366A1 (en) 2000-12-15
KR20000069598A (ko) 2000-11-25
FR15C0060I2 (fr) 2016-04-22
ES2182133T3 (es) 2003-03-01
RU2205012C2 (ru) 2003-05-27
JP4488538B2 (ja) 2010-06-23
UA66779C2 (uk) 2004-06-15
DE69714616D1 (de) 2002-09-12
CN1121875C (zh) 2003-09-24
ID21635A (id) 1999-07-08
SA97180719B1 (ar) 2006-05-13
HU226616B1 (en) 2009-04-28
AU758857B2 (en) 2003-04-03
EP1007094A1 (en) 2000-06-14
SI1007094T1 (en) 2003-02-28
WO1998028009A1 (en) 1998-07-02
CA2275153A1 (en) 1998-07-02
DK1007094T3 (da) 2002-10-28
MY121982A (en) 2006-03-31
FR15C0060I1 (no) 2015-10-23
NO327142B1 (no) 2009-05-04
HUP0000572A2 (hu) 2001-05-28
BR9713974B1 (pt) 2010-02-23
BR9713974A (pt) 2000-04-11
IS5064A (is) 1999-06-03
SK283137B6 (sk) 2003-03-04
JP2001507022A (ja) 2001-05-29
DE69714616T2 (de) 2003-04-03
CZ300635B6 (cs) 2009-07-08
PL190493B1 (pl) 2005-12-30
HUP0000572A3 (en) 2002-10-28
ATE221787T1 (de) 2002-08-15
PL334006A1 (en) 2000-01-31
CN1240362A (zh) 2000-01-05
PT1007094E (pt) 2002-12-31
NO993067D0 (no) 1999-06-21

Similar Documents

Publication Publication Date Title
ID18352A (id) Komposisi-komposisi farmasi
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
DK0938345T3 (da) Vandbaseret farmaceutisk sammensætning
DE59710102D1 (de) Vernetzbare Zusammensetzungen
ID27415A (id) Komposisi farmaseutik
IS5046A (is) Lyfjasamsetningar
ID29262A (id) Komposisi farmasi
ATE209959T1 (de) Mikroverkapselte zusammensetzungen
ATE293672T1 (de) Farbschonende zusammensetzungen
ID27201A (id) Komposisi farmasi
BR9612236A (pt) Composições secas
NO993067L (no) Farmasoeytiske sammensetninger for frysetoerking
ID16781A (id) Formulasi-formulasi farmasi
EE9900440A (et) Farmatseutilised kompositsioonid
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
PT941100E (pt) Composicoes farmaceuticas
EE200000330A (et) Farmatseutilised kompositsioonid
ID26215A (id) Komposisi farmasi
ITMI962628A0 (it) Composizione farmaceutica
NO994436D0 (no) Farmasöytiske sammensetninger
SE9604299D0 (sv) Pharmaceutical composition
SE9601854D0 (sv) Farmaceutisk komposition
ID17133A (id) Komposisi farmasi
SE9604753D0 (sv) Dry powder pharmaceutical formaulation
SE9600141D0 (sv) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK1K Patent expired